The retailer is investing more than $2 million in store renovations, according to building permits filed in Framingham.

CRISPR Therapeutics and Intellia face 2025 volatility, but CRSP’s strong cash and launches make it more attractive than NTLA.

The Massachusetts Department of Public Health has deemed Framingham Union Hospital's current level of maternity services ...

The Cambridge-based biotech company has been trying to reduce operating expenses as it burns cash on its large pipeline.